Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. Why did this happen? Eliquis, which made up about 21% of the companys total sales in the latest reported quarter, faces U.S. market exclusivity loss after 2026. Eliquis, which made up about 21% of the companys total sales in the latest reported quarter, faces U.S. market exclusivity loss after 2026. For more information you can review our Terms of Service and Cookie Policy.
ELF does not block cookies.
( z0 block :ARG0 ( z1 i ) :ARG1 ( z2 cookie ) :polarity - )
(z0 / block-01
    :ARG0 (z1 / i)
    :ARG1 (z2 / cookie)
    :polarity -)
ELF does not block cookies .
z0 :polarity 0
z0 :ARG0 z1
z0 :ARG1 z2